Site Initiation Visit at Prague

On December 5th 2017, the Site Initiation Visit (SIV) was carried out at the Czech study site, the University Hospital of Charles University in Prague. The study management team, composed of representatives from the Sponsor, Universitätsklinikum Erlangen, and Therakind Ltd. visited the hospital facilities, met with site staff around Principal Investigator Dr. Pavla Pokorná and implemented the remaining necessary training. Following the SIV, the investigational medicinal products were sent to the Czech site and the highly motivated local study team is about to start screening and recruitment.